Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 

QPP Measure #PIMSH16

Appropriate Antiemetic Therapy for High- and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center

Percentage of cancer patients aged 18 years and older treated with high- or moderate-emetic-risk antineoplastic agents in the infusion center who are administered appropriate pre-treatment antiemetic therapy

Submission Methods: Registry

The following codes apply for this QPP measure:

HCPCS Codes

CodeDescription
M0001Advancing cancer care mips value pathways
demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.